Zhejiang Anglikang Pharmaceutical Co Ltd Class A Total Liabilities

Latest as of June 2026: CN¥1.07 Billion CNY ≈ $157.14 Million USD

Zhejiang Anglikang Pharmaceutical Co Ltd Class A total liabilities. Based on the latest financial reports, Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940) has total liabilities worth CN¥1.07 Billion CNY (≈ $157.14 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Zhejiang Anglikang Pharmaceutical Co Ltd (002940) asset resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Zhejiang Anglikang Pharmaceutical Co Ltd Class A (2014–2025)

Total liabilities of Zhejiang Anglikang Pharmaceutical Co Ltd Class A from 2014 to 2025. This chart illustrates how Zhejiang Anglikang Pharmaceutical Co Ltd Class A's total liabilities have evolved over time, based on quarterly financial data.

Zhejiang Anglikang Pharmaceutical Co Ltd Class A Competitors by Total Liabilities

The table below lists competitors of Zhejiang Anglikang Pharmaceutical Co Ltd Class A ranked by their total liabilities.

Company	Country	Total Liabilities
Time Publishing and Media Co Ltd Class A SHG:600551	China	CN¥2.50 Billion
Shandong Link Science and Technology Co Ltd SHE:001207	China	CN¥1.02 Billion
Hite Jinro KO:000080	Korea	₩2.19 Trillion
Xianheng International Science & Technology Co Ltd SHG:605056	China	CN¥1.35 Billion
Tianma Bearing Group Co Ltd SHE:002122	China	CN¥1.41 Billion
Shenzhen Terca Technology Co Ltd SHE:002213	China	CN¥395.65 Million
Zenner Metering Technology (Shanghai) Ltd. A SHE:301303	China	CN¥1.18 Billion
Sunway Co Ltd SHG:603333	China	CN¥2.39 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down Zhejiang Anglikang Pharmaceutical Co Ltd Class A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 002940 asset base.

Liquidity & Leverage Metrics

Zhejiang Anglikang Pharmaceutical Co Ltd Class A Total Liabilities Ratios Explained

Zhejiang Anglikang Pharmaceutical Co Ltd Class A total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.99	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.65	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.36	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Zhejiang Anglikang Pharmaceutical Co Ltd Class A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Zhejiang Anglikang Pharmaceutical Co Ltd Class A (2014–2025)

The table below shows the annual total liabilities of Zhejiang Anglikang Pharmaceutical Co Ltd Class A from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥1.08 Billion ≈ $158.56 Million	-7.87%
2024-12-31	CN¥1.18 Billion ≈ $172.10 Million	-0.98%
2023-12-31	CN¥1.19 Billion ≈ $173.80 Million	+25.03%
2022-12-31	CN¥949.93 Million ≈ $139.00 Million	+56.07%
2021-12-31	CN¥608.64 Million ≈ $89.06 Million	+8.15%
2020-12-31	CN¥562.78 Million ≈ $82.35 Million	+52.72%
2019-12-31	CN¥368.51 Million ≈ $53.92 Million	-26.19%
2018-12-31	CN¥499.27 Million ≈ $73.06 Million	-2.56%
2017-12-31	CN¥512.41 Million ≈ $74.98 Million	+27.93%
2016-12-31	CN¥400.56 Million ≈ $58.61 Million	-25.22%
2015-12-31	CN¥535.63 Million ≈ $78.38 Million	+4.14%
2014-12-31	CN¥514.36 Million ≈ $75.27 Million	--

About Zhejiang Anglikang Pharmaceutical Co Ltd Class A

SHE:002940 China Drug Manufacturers - Specialty & Generic

Market Cap

$749.79 Million

CN¥5.12 Billion CNY

Market Cap Rank

#9911 Global

#2545 in China

Share Price

CN¥25.40

Change (1 day)

+7.54%

52-Week Range

CN¥20.95 - CN¥47.00

All Time High

CN¥249286.54